In most cases, treatments are successful in curing or controlling papillary thyroid cancer. Surgery is the main treatment option for this disease, though doctors may also recommend radiation therapy.

ImmunityBio Inc. (NASDAQ:IBRX) is one of the best NASDAQ stocks under $30 to buy. On March 17, ImmunityBio announced that the National Comprehensive Cancer Network/NCCN updated its 2026 Clinical ...

CEO Richard Adcock used a presentation at the Citizens Life Sciences Conference to outline the company’s commercial progress ...

Patients with micropapillary thyroid cancer--small tumors equal to or less than 1 centimeter--and tumors even smaller, less than 1 millimeter (mm)--are more common and not without a risk as previously ...

ImmunityBio has received approval from the Pharmaceutical Administration Bureau (ISAF) of the Macau Special Administrative ...

What is Papillary Thyroid Cancer? Papillary thyroid cancer is the most common type of thyroid cancers accounting for about 80% of all diagnosed thyroid cancers. The thyroid gland is located in front ...

Carcinomas of the extrahepatic bile ducts are uncommon neoplasms that are morphologically heterogeneous and associated with a poor prognosis. We have previously shown that the noninvasive and ...

The concave zone of papillary calculi can contain a range of calcified lesions, from little HAP residues to typical well-developed HAP plaques, also known as Randall's plaques. The morphology of each ...

‌Giant papillary conjunctivitis (GPC) causes swelling, redness, and irritation in the lining of the membrane inside your eyelids. Contact lens wearers have the highest risk of developing GPC. People ...

Papillary renal-cell carcinoma, which accounts for 15 to 20% of renal-cell carcinomas, is a heterogeneous disease that consists of various types of renal cancer, including tumors with indolent, ...